Biggest News Aggregation in the World
📰 Celularity Inc News

Page 12 - Celularity Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Celularity Inc. Real-time updates on events, politics, business and more.

Antengene Announces Research Collaboration with Celularity to Evaluate the Potential Therapeutic Synergy of Combining Antengene's Best-in-Class Bispecific Antibody with Celularity's Natural Killer Cell Platform

- This research collaboration marks Antengene's entry into the field of cellular medicines. SHANGHAI and HONG KONGJuly 19, 2022 /PRNewswire/ --Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that it has entered intoa pre-clinical research collaboration ...
Bo Shan United States Hong Kong South Korea Jay Mei Asia Pacific

Celularity (NASDAQ:CELU) & Kezar Life Sciences (NASDAQ:KZR) Critical Comparison

Celularity (NASDAQ:CELU – Get Rating) and Kezar Life Sciences (NASDAQ:KZR – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Celularity and Kezar […]
United States New Jersey South San Francisco Florham Park Kezar Life Sciences Company Profile Get Rating Kezar Life Sciences Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Platelet Rich Plasma Market is expected to expand at a steady 6% CAGR through 2031

In a recent market survey, ESOMAR-certified consulting firm Future Market Insights (FMI) forecasts an impressive growth outlook for the platelet-rich plasma (PRP) market. The market valuation reached US$ 370.78 Mn in 2021 and is poised to expand at a 6% CAGR through 2031.Growth registered in the platelet-rich plasma...
New York United States United Arab Emirates South Korea Asia Pacific Cesca Therapeutics Inc

Platelet Rich Plasma Market is expected to expand at a steady 6% CAGR through 2031

In a recent market survey, ESOMAR-certified consulting firm Future Market Insights (FMI) forecasts an impressive growth outlook for the platelet-rich plasma (PRP) market. The market valuation reached US$ 370.78 Mn in 2021 and is poised to expand at a 6% CAGR through 2031.Growth registered in the platelet-rich plasma...
New York United States United Arab Emirates South Korea Asia Pacific Cesca Therapeutics Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science